For: | Bajer L, Kverka M, Kostovcik M, Macinga P, Dvorak J, Stehlikova Z, Brezina J, Wohl P, Spicak J, Drastich P. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World J Gastroenterol 2017; 23(25): 4548-4558 [PMID: 28740343 DOI: 10.3748/wjg.v23.i25.4548] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i25/4548.htm |
Number | Citing Articles |
1 |
Thijmen Visseren, Gwenny Manel Fuhler, Nicole Stephanie Erler, Yoena Roos Anna Nossent, Herold Johnny Metselaar, Jan Nicolaas Maria IJzermans, Sarwa Darwish Murad, Maikel Petrus Peppelenbosch. Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant – a pilot study. Transplant International 2020; 33(11): 1424 doi: 10.1111/tri.13692
|
2 |
Ping Jiang, Siqi Ji, Dan Su, Yu Zhao, Viriania Berta Esperanca Goncalves, Guifang Xu, Mingming Zhang. The biofunction of Akkermansia muciniphila in intestinal-related diseases. Microbiome Research Reports 2024; 3(4) doi: 10.20517/mrr.2024.12
|
3 |
Michaela Brichová, Petra Svozílková, Aneta Klímová, Otakar Dušek, Miloslav Kverka, Jarmila Heissigerová. Microbiome and Uveitides. A Review. Czech and Slovak Ophthalmology 2022; 78(2): 47 doi: 10.31348/2021/30
|
4 |
José Carlos Andrade, Diana Almeida, Melany Domingos, Catarina Leal Seabra, Daniela Machado, Ana Cristina Freitas, Ana Maria Gomes. Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies. Frontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.00550
|
5 |
Prasanna Kulkarni, Poornima Devkumar, Indranil Chattopadhyay. Could dysbiosis of inflammatory and anti-inflammatory gut bacteria have an implications in the development of type 2 diabetes? A pilot investigation. BMC Research Notes 2021; 14(1) doi: 10.1186/s13104-021-05466-2
|
6 |
Kunli Wang, Bei Li, Rao Fu, Zefang Jiang, Xin Wen, Yuanying Ni. Bentong ginger oleoresin mitigates liver injury and modulates gut microbiota in mouse with nonalcoholic fatty liver disease induced by high‐fat diet. Journal of Food Science 2022; 87(3): 1268 doi: 10.1111/1750-3841.16076
|
7 |
Jinyu Zhao, Ping Yue, Ningning Mi, Matu Li, Wenkang Fu, Xianzhuo Zhang, Long Gao, Mingzhen Bai, Liang Tian, Ningzu Jiang, Yawen Lu, Haidong Ma, Chunlu Dong, Yong Zhang, Hengwei Zhang, Jinduo Zhang, Yanxian Ren, Azumi Suzuki, Peng F. Wong, Kiyohito Tanaka, Rungsun Rerknimitr, Henrik H. Junger, Tan T. Cheung, Emmanuel Melloul, Nicolas Demartines, Joseph W. Leung, Jia Yao, Jinqiu Yuan, Yanyan Lin, Hans J. Schlitt, Wenbo Meng. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications. Medical Review 2024; 4(4): 326 doi: 10.1515/mr-2024-0029
|
8 |
Tyler C. Hammond, Elizabeth Powell, Stefan J. Green, George Chlipala, Jacqueline Frank, Andrew T. Yackzan, Lucille M. Yanckello, Ya-Hsuan Chang, Xin Xing, Sally Heil, Joe E. Springer, Keith Pennypacker, Arnold Stromberg, Lumy Sawaki, Ai-Ling Lin. Functional recovery outcomes following acute stroke is associated with abundance of gut microbiota related to inflammation, butyrate and secondary bile acid. Frontiers in Rehabilitation Sciences 2022; 3 doi: 10.3389/fresc.2022.1017180
|
9 |
Martin Cornillet, Daniel Geanon, Annika Bergquist, Niklas K. Björkström. Immunobiology of primary sclerosing cholangitis. Hepatology 2024; doi: 10.1097/HEP.0000000000001080
|
10 |
Katja Kalenyak, Anitha Isaiah, Romy M Heilmann, Jan S Suchodolski, Iwan A Burgener. Comparison of the intestinal mucosal microbiota in dogs diagnosed with idiopathic inflammatory bowel disease and dogs with food-responsive diarrhea before and after treatment. FEMS Microbiology Ecology 2018; 94(2) doi: 10.1093/femsec/fix173
|
11 |
Nicholas E. Ilott, Mastura Neyazi, Carolina V. Arancibia-Cárcamo, Fiona Powrie, Alessandra Geremia. Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease. Wellcome Open Research 2021; 6: 199 doi: 10.12688/wellcomeopenres.16901.1
|
12 |
Huixiang Yao, Yan Shi, Junqing Yuan, Ri Sa, Wei Chen, Xinjian Wan. Matrine protects against DSS-induced murine colitis by improving gut barrier integrity, inhibiting the PPAR-α signaling pathway, and modulating gut microbiota. International Immunopharmacology 2021; 100: 108091 doi: 10.1016/j.intimp.2021.108091
|
13 |
Oscar Illescas, Miriam Rodríguez-Sosa, Manuela Gariboldi. Mediterranean Diet to Prevent the Development of Colon Diseases: A Meta-Analysis of Gut Microbiota Studies. Nutrients 2021; 13(7): 2234 doi: 10.3390/nu13072234
|
14 |
Ji-Won Park, Jung-Hee Kim, Sung-Eun Kim, Jang Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Hyoung-Su Kim, Ki Tae Suk, Dong Joon Kim. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines 2022; 10(6): 1288 doi: 10.3390/biomedicines10061288
|
15 |
Amir Kalani, James H. Tabibian, Keith D. Lindor. Emerging therapeutic targets for primary sclerosing cholangitis. Expert Opinion on Orphan Drugs 2018; 6(7): 393 doi: 10.1080/21678707.2018.1490643
|
16 |
Pascale Vonaesch, Evan Morien, Lova Andrianonimiadana, Hugues Sanke, Jean-Robert Mbecko, Kelsey E. Huus, Tanteliniaina Naharimanananirina, Bolmbaye Privat Gondje, Synthia Nazita Nigatoloum, Sonia Sandrine Vondo, Jepthé Estimé Kaleb Kandou, Rindra Randremanana, Maheninasy Rakotondrainipiana, Florent Mazel, Serge Ghislain Djorie, Jean-Chrysostome Gody, B. Brett Finlay, Pierre-Alain Rubbo, Laura Wegener Parfrey, Jean-Marc Collard, Philippe J. Sansonetti, Emilson Jean Andriatahirintsoa, Laurence Barbot-Trystram, Robert Barouki, Alexandra Bastaraud, Jean-Marc Collard, Maria Doria, Darragh Duffy, Aurélie Etienne, B. Brett Finlay, Serge Ghislain Djorie, Tamara Giles-Vernick, Jean-Chrysostome Gody, Milena Hasan, Jean-Michel Héraud, François Huetz, Francis Allan Hunald, Nathalie Kapel, Jean-Pierre Lombart, Alexandre Manirakiza, Synthia Nazita Nigatoloum, Sophie Novault, Laura Wegener-Parfrey, Lisette Raharimalala, Maheninasy Rakotondrainipiana, Rindra Randremanana, Harifetra Mamy Richard Randriamizao, Frédérique Randrianirina, Annick Robinson, Pierre-Alain Rubbo, Philippe Sansonetti, Laura Schaeffer, Ionela Gouandjika-Vassilache, Pascale Vonaesch, Sonia Sandrine Vondo, Inès Vigan-Womas. Stunted childhood growth is associated with decompartmentalization of the gastrointestinal tract and overgrowth of oropharyngeal taxa. Proceedings of the National Academy of Sciences 2018; 115(36) doi: 10.1073/pnas.1806573115
|
17 |
Ewelina Flegiel, Magdalena Piotrowska, Magdalena Ptasznik, Aleksandra Baran, Justyna Lenart, Miłosz Podrażka, Joanna Mazurek, Hubert Stachowicz, Weronika Bartos, Monika Adamczyk. Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer. Prospects in Pharmaceutical Sciences 2024; 22(4): 7 doi: 10.56782/pps.229
|
18 |
Natalia Molinero, Diego Taladrid, Irene Zorraquín-Peña, Miguel de Celis, Ignacio Belda, Alex Mira, Begoña Bartolomé, M. Victoria Moreno-Arribas. Ulcerative Colitis Seems to Imply Oral Microbiome Dysbiosis. Current Issues in Molecular Biology 2022; 44(4): 1513 doi: 10.3390/cimb44040103
|
19 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
20 |
Hanxue Sun, Wenwu Xu, Tiantian Gu, Jing Sun, Chengfeng Li, Li Chen, Yong Tian, Guoqin Li, Lizhi Lu, Tao Zeng. Association of residual feed intake with intestinal microbiome and metabolome in laying period of ducks. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1138914
|
21 |
Tihong Shao, Ronald Hsu, Desiree L. Rafizadeh, Li Wang, Christopher L. Bowlus, Narendra Kumar, Jayshree Mishra, Suraj Timilsina, William M. Ridgway, M. Eric Gershwin, Aftab A. Ansari, Zongwen Shuai, Patrick S.C. Leung. The gut ecosystem and immune tolerance. Journal of Autoimmunity 2023; 141: 103114 doi: 10.1016/j.jaut.2023.103114
|
22 |
Christopher L. Bowlus. The Rose and Mackay Textbook of Autoimmune Diseases. 2024; : 845 doi: 10.1016/B978-0-443-23947-2.00020-5
|
23 |
Klara Kostovcikova, Stepan Coufal, Natalie Galanova, Alena Fajstova, Tomas Hudcovic, Martin Kostovcik, Petra Prochazkova, Zuzana Jiraskova Zakostelska, Martina Cermakova, Blanka Sediva, Marek Kuzma, Helena Tlaskalova-Hogenova, Miloslav Kverka. Diet Rich in Animal Protein Promotes Pro-inflammatory Macrophage Response and Exacerbates Colitis in Mice. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00919
|
24 |
Nehal Adel Abdelsalam, Shaimaa M. Hegazy, Ramy K. Aziz.
The curious case of
Prevotella copri
. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2249152
|
25 |
Ting Zhang, Xinghui Ji, Gaochen Lu, Faming Zhang. The potential of Akkermansia muciniphila in inflammatory bowel disease. Applied Microbiology and Biotechnology 2021; 105(14-15): 5785 doi: 10.1007/s00253-021-11453-1
|
26 |
Jumpei Fujiki, Bernd Schnabl. Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases. JHEP Reports 2023; 5(12): 100909 doi: 10.1016/j.jhepr.2023.100909
|
27 |
Nina Qin, Yan Meng, Zhihua Ma, Zhaoping Li, Zhenzhen Hu, Chenyi Zhang, Liyong Chen. Pea Starch-Lauric Acid Complex Alleviates Dextran Sulfate Sodium-Induced Colitis in C57BL/6J Mice. Nutrition and Cancer 2023; 75(8): 1673 doi: 10.1080/01635581.2023.2223789
|
28 |
Qinhui Tang, Limin Li, Yantong Li, Wenmeng Yin, Xiaolin Zhong. Association between inflammatory bowel disease and primary sclerosing cholangitis: Insights from bibliometric analysis. Medicine 2024; 103(21): e38257 doi: 10.1097/MD.0000000000038257
|
29 |
Oliwia Zakerska-Banaszak, Hanna Tomczak, Marcin Gabryel, Alina Baturo, Lukasz Wolko, Michal Michalak, Natalia Malinska, Dorota Mankowska-Wierzbicka, Piotr Eder, Agnieszka Dobrowolska, Ryszard Slomski, Marzena Skrzypczak-Zielinska. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81628-3
|
30 |
Xiaoyu Huang, Huihui Li, Feng Cheng, Ligang Wang, Guoqing Cao, Lixian Wang, Lijun Shi. Multi‐omics analyses reveal the interaction between colonic microbiota and host in Min and Yorkshire pigs. Animal Research and One Health 2023; doi: 10.1002/aro2.39
|
31 |
M.V. Gryaznova, S.A. Solodskikh, A.V. Panevina, M.Y. Syromyatnikov, Yu.D. Dvoretskaya, T.N. Sviridova, E.S. Popov, V.N. Popov. Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia. Heliyon 2021; 7(3): e06432 doi: 10.1016/j.heliyon.2021.e06432
|
32 |
Chen Xue, Ganglei Li, Xinyu Gu, Yuanshuai Su, Qiuxian Zheng, Xin Yuan, Zhengyi Bao, Juan Lu, Lanjuan Li. Health and Disease:Akkermansia muciniphila, the Shining Star of the Gut Flora. Research 2023; 6 doi: 10.34133/research.0107
|
33 |
C R H Hedin, S R Vavricka, A J Stagg, A Schoepfer, T Raine, L Puig, U Pleyer, A Navarini, A E van der Meulen-de Jong, J Maul, K Katsanos, A Kagramanova, T Greuter, Y González-Lama, F van Gaalen, P Ellul, J Burisch, D Bettenworth, M D Becker, G Bamias, F Rieder. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy. Journal of Crohn's and Colitis 2019; 13(5): 541 doi: 10.1093/ecco-jcc/jjy191
|
34 |
Enyin Li, Ting Wang, Rui Zhou, Ziwei Zhou, Chongyang Zhang, Weihua Wu, Kai He. Myricetin and myricetrin alleviate liver and colon damage in a chronic colitis mice model: Effects on tight junction and intestinal microbiota. Journal of Functional Foods 2021; 87: 104790 doi: 10.1016/j.jff.2021.104790
|
35 |
Na Han, Xianhui Peng, Tingting Zhang, Yujun Qiang, Xiuwen Li, Wen Zhang. Temporal dynamics and species-level complexity of Prevotella spp. in the human gut microbiota: implications for enterotypes and health. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1414000
|
36 |
Tharsius W. Raja, Duraipandiyan Veeramuthu, Ignacimuthu Savarimuthu, Naif A. Al-Dhabi. Current Trends in the Treatment of Systemic Lupus Erythematosus. Current Pharmaceutical Design 2020; 26(22): 2602 doi: 10.2174/1381612826666200211122633
|
37 |
Huan-Ting Shen, Yi-Ting Fang, Wan-Hua Tsai, Chia-Hsuan Chou, Ming-Shyan Huang, Yao-Tsung Yeh, Jiun-Ting Wu, Cheng-Hsieh Huang, Bing-Yen Wang, Wen-Wei Chang. A Lactobacillus Combination Ameliorates Lung Inflammation in an Elastase/LPS—induced Mouse Model of Chronic Obstructive Pulmonary Disease. Probiotics and Antimicrobial Proteins 2024; doi: 10.1007/s12602-024-10300-9
|
38 |
Dan Zhang, Yong-Ping Jian, Yu-Ning Zhang, Yao Li, Li-Ting Gu, Hui-Hui Sun, Ming-Di Liu, Hong-Lan Zhou, Yi-Shu Wang, Zhi-Xiang Xu. Short-chain fatty acids in diseases. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01219-9
|
39 |
Anabel Martinez Lyons, Luke Boulter. NOTCH signalling – a core regulator of bile duct disease?. Disease Models & Mechanisms 2023; 16(9) doi: 10.1242/dmm.050231
|
40 |
Teresa Da Cunha, Haleh Vaziri, George Y. Wu. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review. Journal of Clinical and Translational Hepatology 2022; 10(3): 531 doi: 10.14218/JCTH.2021.00344
|
41 |
A. Y. Tikunov, A. N. Shvalov, V. V. Morozov, I. V. Babkin, G. V. Seledtsova, I. O. Voloshina, I. P. Ivanova, A. V. Bardasheva, V. V. Morozova, V. V. Vlasov, N. V. Tikunova. Taxonomic composition and biodiversity of the gut microbiome from patients with irritable bowel syndrome, ulcerative colitis, and asthma. Vavilov Journal of Genetics and Breeding 2022; 25(8): 864 doi: 10.18699/VJ21.100
|
42 |
Xiru Liang, Ziwei Wang, Qiuai Shu, Xindi Huang, Jinhai Wang, Jian Wu, Na Liu, Ning Xie. A bidirectional two-sample Mendelian randomization using the gut microbiota to reveal potential therapeutic targets for primary sclerosing cholangitis. European Journal of Gastroenterology & Hepatology 2024; 36(2): 147 doi: 10.1097/MEG.0000000000002666
|
43 |
Chinenye R. Dike, Corrine Hanson, H. Dele Davies, Stephen Obaro, Fang Yu, James Harper, Helen Grace, Jeffrey Lebensburger, Chittalsinh Raulji, Jihyun Ma, Peter Mannon. The relationship between nutrition, gut dysbiosis, and pediatric sickle cell pain outcomes: A pilot study. Pediatric Blood & Cancer 2023; 70(7) doi: 10.1002/pbc.30397
|
44 |
Ningning Li, Liwei Gao, Yuping Ge, Lin Zhao, Yingyi Wang, Chunmei Bai. Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer. Heliyon 2024; 10(12): e32770 doi: 10.1016/j.heliyon.2024.e32770
|
45 |
Laura Vega, Laura Bohórquez, Juan David Ramírez, Marina Muñoz. Do we need to change our perspective about gut biomarkers? A public data mining approach to identify differentially abundant bacteria in intestinal inflammatory diseases. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.918237
|
46 |
Artem Y. Tikunov, Valeria A. Fedorets, Evgenia V. Shrainer, Vitaliy V. Morozov, Valeria I. Bystrova, Nina V. Tikunova. Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation. Journal of Clinical Medicine 2023; 12(24): 7702 doi: 10.3390/jcm12247702
|
47 |
Amy L. D’Agata, Jing Wu, Manushi K. V. Welandawe, Samia V. O. Dutra, Bradley Kane, Maureen W. Groer. Effects of early life NICU stress on the developing gut microbiome. Developmental Psychobiology 2019; 61(5): 650 doi: 10.1002/dev.21826
|
48 |
Xu-Xia He, Ying-He Li, Peng-Guang Yan, Xiang-Chen Meng, Chu-Yan Chen, Ke-Min Li, Jing-Nan Li. Relationship between clinical features and intestinal microbiota in Chinese patients with ulcerative colitis. World Journal of Gastroenterology 2021; 27(28): 4722-4737 doi: 10.3748/wjg.v27.i28.4722
|
49 |
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
|
50 |
Yong-Hua Shen, Hao Zhu, Lin Zhou, Yan-Qing Zheng, Zhan Zhang, Ying Xie, Zhen-Qing Liu, Chun-Yan Peng, Lei Wang, Cheng Zhao, Xiao-Qi Zhang. In inflammatory bowel disease and extraintestinal manifestations: What role does microbiome play?. Engineered Regeneration 2023; 4(4): 337 doi: 10.1016/j.engreg.2023.04.005
|
51 |
Damjana Bogatic, Robert V. Bryant, Kate D. Lynch, Samuel P. Costello. Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2023; 57(1): 23 doi: 10.1111/apt.17251
|
52 |
Zi-Jia Zhang, Hong-Lei Qu, Na Zhao, Jing Wang, Xiu-Yan Wang, Rong Hai, Bin Li. Assessment of Causal Direction Between Gut Microbiota and Inflammatory Bowel Disease: A Mendelian Randomization Analysis. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.631061
|
53 |
Timur Liwinski, Melina Heinemann, Christoph Schramm. The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts. Seminars in Immunopathology 2022; 44(4): 485 doi: 10.1007/s00281-022-00936-6
|
54 |
Ting Zhang, Pan Li, Xia Wu, Gaochen Lu, Cicilia Marcella, Xinghui Ji, Guozhong Ji, Faming Zhang. Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation. Applied Microbiology and Biotechnology 2020; 104(23): 10203 doi: 10.1007/s00253-020-10948-7
|
55 |
Mikal Jacob Hole, Kristin Kaasen Jørgensen, Kristian Holm, Peder R. Braadland, Malin Holm Meyer‐Myklestad, Asle Wilhelm Medhus, Dag Henrik Reikvam, Alexandra Götz, Krzysztof Grzyb, Kirsten Muri Boberg, Tom Hemming Karlsen, Martin Kummen, Johannes R. Hov. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation. Hepatology 2023; 77(3): 715 doi: 10.1002/hep.32773
|
56 |
Thomas Ryan, Sophia Ling, Andrew Trinh, Jonathan P. Segal. The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis. Best Practice & Research Clinical Gastroenterology 2024; : 101945 doi: 10.1016/j.bpg.2024.101945
|
57 |
Aipeng Mao, Weigang Zhao, Yuhang Zhu, Fantao Kong, Danyang Chen, Huazhe Si, Chao Xu. Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier. Microorganisms 2023; 11(11): 2616 doi: 10.3390/microorganisms11112616
|
58 |
Liang Dai, Yingjue Tang, Wenjun Zhou, Yanqi Dang, Qiaoli Sun, Zhipeng Tang, Mingzhe Zhu, Guang Ji. Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.620724
|
59 |
Langsha Liu, Juan Su, Rui Li, Fanyan Luo. Changes in Intestinal Flora Structure and Metabolites Are Associated With Myocardial Fibrosis in Patients With Persistent Atrial Fibrillation. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.702085
|
60 |
Valeria Maccauro, Francesca Fianchi, Antonio Gasbarrini, Francesca Romana Ponziani. Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications. Digestive Diseases 2024; 42(4): 369 doi: 10.1159/000538493
|
61 |
Tian Liu, Qi Xiong, Lingling Li, Yi Hu. Intestinal Microbiota Predicts Lung Cancer Patients at Risk of Immune-Related Diarrhea. Immunotherapy 2019; 11(5): 385 doi: 10.2217/imt-2018-0144
|
62 |
Li Yang, Zhao Xiang, Jinmei Zou, Yu Zhang, Yuanpiao Ni, Jing Yang. Comprehensive Analysis of the Relationships Between the Gut Microbiota and Fecal Metabolome in Individuals With Primary Sjogren’s Syndrome by 16S rRNA Sequencing and LC–MS-Based Metabolomics. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.874021
|
63 |
Chao Yan, Stephane Koda, Jing Wu, Bei‐Bei Zhang, Qian Yu, Mihai G. Netea, Ren‐Xian Tang, Kui‐Yang Zheng. Roles of Trained Immunity in the Pathogenesis of Cholangiopathies: A Therapeutic Target. Hepatology 2020; 72(5): 1838 doi: 10.1002/hep.31395
|
64 |
Marie Vibeke Vestergaard, Kristine H. Allin, Carsten Eriksen, Oliwia Zakerska‐Banaszak, Ramesh P. Arasaradnam, Mohammad T. Alam, Karsten Kristiansen, Susanne Brix, Tine Jess. Gut microbiota signatures in inflammatory bowel disease. United European Gastroenterology Journal 2024; 12(1): 22 doi: 10.1002/ueg2.12485
|
65 |
Kyung Won Lee, Minseok Kim, Chang Hoon Lee, Vincent B. Young. Treatment of Dextran Sulfate Sodium-Induced Colitis with Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor MI-2 Is Associated with Restoration of Gut Immune Function and the Microbiota. Infection and Immunity 2018; 86(12) doi: 10.1128/IAI.00091-18
|
66 |
Yanping Zheng, Ying Ran, Hongxia Zhang, Bangmao Wang, Lu Zhou. The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.715852
|
67 |
Brian White, John D Sterrett, Zoya Grigoryan, Lauren Lally, Jared D Heinze, Hyder Alikhan, Christopher A Lowry, Lark J Perez, Joshua DeSipio, Sangita Phadtare. Characterization of gut microbiome and metabolome in <i>Helicobacter pylori</i> patients in an underprivileged community in the United States. World Journal of Gastroenterology 2021; 27(33): 5575-5594 doi: 10.3748/wjg.v27.i33.5575
|
68 |
Burcin Özdirik, Bernd Schnabl. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts. Cellular and Molecular Gastroenterology and Hepatology 2024; 17(3): 423 doi: 10.1016/j.jcmgh.2023.12.005
|
69 |
Pavel Vodicka, Marketa Urbanova, Pavol Makovicky, Kristyna Tomasova, Michal Kroupa, Rudolf Stetina, Alena Opattova, Klara Kostovcikova, Anna Siskova, Michaela Schneiderova, Veronika Vymetalkova, Ludmila Vodickova. Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer Patients. International Journal of Molecular Sciences 2020; 21(7): 2473 doi: 10.3390/ijms21072473
|
70 |
Pauline Raoul, Marco Cintoni, Marta Palombaro, Luisa Basso, Emanuele Rinninella, Antonio Gasbarrini, Maria Cristina Mele. Food Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis. Microorganisms 2022; 10(1): 167 doi: 10.3390/microorganisms10010167
|
71 |
Aalam Sohal, Kris V. Kowdley. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert Opinion on Investigational Drugs 2024; 33(4): 335 doi: 10.1080/13543784.2024.2330738
|
72 |
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, Maria De Angelis, Francesco Maria Calabrese, Mauro D’Amato, David Q.-H. Wang, Agostino Di Ciaula. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2021; 10(1): 83 doi: 10.3390/biomedicines10010083
|
73 |
Dayan sun, Chuanping Xie, Yong Zhao, Junmin Liao, Shuangshuang Li, Yanan Zhang, Dingding Wang, Kaiyun Hua, Yichao Gu, Jingbin Du, Guoxian Huang, Jinshi Huang. The gut microbiota-bile acid axis in cholestatic liver disease. Molecular Medicine 2024; 30(1) doi: 10.1186/s10020-024-00830-x
|
74 |
Nader Kameli, Heike E. F. Becker, Tessa Welbers, Daisy M. A. E. Jonkers, John Penders, Paul Savelkoul, Frank R. Stassen. Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn’s Disease Patients. Cells 2021; 10(10): 2795 doi: 10.3390/cells10102795
|
75 |
Josip Stojic, Michał Kukla, Ivica Grgurevic. The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status. Diagnostics 2023; 13(18): 2960 doi: 10.3390/diagnostics13182960
|
76 |
Frances Widjaja, Ivonne M. C. M. Rietjens. From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes. Biomedicines 2023; 11(10): 2658 doi: 10.3390/biomedicines11102658
|
77 |
Kathleen Machiels, Marta Pozuelo del Río, Adrian Martinez-De la Torre, Zixuan Xie, Victòria Pascal Andreu, João Sabino, Alba Santiago, David Campos, Albert Wolthuis, André D’Hoore, Gert De Hertogh, Marc Ferrante, Chaysavanh Manichanh, Séverine Vermeire. Early Postoperative Endoscopic Recurrence in Crohn’s Disease Is Characterised by Distinct Microbiota Recolonisation. Journal of Crohn's and Colitis 2020; 14(11): 1535 doi: 10.1093/ecco-jcc/jjaa081
|
78 |
Gajalakshmi Ramanathan, Brianna M Hoover, Angela G Fleischman. Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN. Cancers 2020; 12(8): 2038 doi: 10.3390/cancers12082038
|
79 |
Emily Read, Michael A. Curtis, Joana F. Neves. The role of oral bacteria in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 2021; 18(10): 731 doi: 10.1038/s41575-021-00488-4
|
80 |
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2024; 80(4): 965 doi: 10.1097/HEP.0000000000000506
|
81 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado. Gastroenterología y Hepatología 2019; 42(5): 316 doi: 10.1016/j.gastrohep.2019.02.004
|
82 |
Marica Cariello, Raffaella M. Gadaleta, Antonio Moschetta. The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment. Current Opinion in Gastroenterology 2022; 38(2): 136 doi: 10.1097/MOG.0000000000000807
|
83 |
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Milena Peruhova, Georgi H. Vasilev, Georgi V. Vasilev, Metodija Sekulovski, Snezhina Lazova, Milena Gulinac, Latchezar Tomov, Antoaneta Mihova, Tsvetelina Velikova. Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases. Gastroenterology Insights 2023; 14(4): 575 doi: 10.3390/gastroent14040041
|
84 |
Tyler A. Rice, Agata A. Bielecka, Mytien T. Nguyen, Connor E. Rosen, Deguang Song, Nicole D. Sonnert, Yi Yang, Yiyun Cao, Varnica Khetrapal, Jason R. Catanzaro, Anjelica L. Martin, Saleh A. Rashed, Shana R. Leopold, Liming Hao, Xuezhu Yu, David van Dijk, Aaron M. Ring, Richard A. Flavell, Marcel R. de Zoete, Noah W. Palm. Interspecies commensal interactions have nonlinear impacts on host immunity. Cell Host & Microbe 2022; 30(7): 988 doi: 10.1016/j.chom.2022.05.004
|
85 |
Janett Nörenberg, Stefanie Vogler, Andreas Stallmach. Inflammatory Bowel Disease Nursing Manual. 2019; : 113 doi: 10.1007/978-3-319-75022-4_14
|
86 |
Nicholas E. Ilott, Mastura Neyazi, Carolina V. Arancibia-Cárcamo, Fiona Powrie, Alessandra Geremia. Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease. Wellcome Open Research 2022; 6: 199 doi: 10.12688/wellcomeopenres.16901.2
|
87 |
Alessandra Lo Presti, Francesca Zorzi, Federica Del Chierico, Annamaria Altomare, Silvia Cocca, Alessandra Avola, Fabiola De Biasio, Alessandra Russo, Eleonora Cella, Sofia Reddel, Emma Calabrese, Livia Biancone, Giovanni Monteleone, Michele Cicala, Silvia Angeletti, Massimo Ciccozzi, Lorenza Putignani, Michele Pier Luca Guarino. Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01655
|
88 |
Atsuto Kayashima, Tomohisa Sujino, Seiichiro Fukuhara, Kentaro Miyamoto, Yoko Kubosawa, Masataka Ichikawa, Shintaro Kawasaki, Kaoru Takabayashi, Eisuke Iwasaki, Motohiko Kato, Akira Honda, Takanori Kanai, Nobuhiro Nakamoto. Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis. Hepatology Communications 2024; 8(6) doi: 10.1097/HC9.0000000000000452
|
89 |
Xue Zhu, Gaichao Hong, Ying Li, Pengshuo Yang, Mingyue Cheng, Lei Zhang, Yuxue Li, Lei Ji, Gangping Li, Chaoyun Chen, Chaofang Zhong, Yu Jin, Min Yang, Hanhua Xiong, Wei Qian, Zhen Ding, Kang Ning, Xiaohua Hou, Kevin R. Theis. Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Microbiology Spectrum 2021; 9(3) doi: 10.1128/Spectrum.01255-21
|
90 |
Hana Čipčić Paljetak, Anja Barešić, Marina Panek, Mihaela Perić, Mario Matijašić, Ivana Lojkić, Ana Barišić, Darija Vranešić Bender, Dina Ljubas Kelečić, Marko Brinar, Mirjana Kalauz, Marija Miličević, Dora Grgić, Nikša Turk, Irena Karas, Silvija Čuković-Čavka, Željko Krznarić, Donatella Verbanac. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2083419
|
91 |
Kerri Glassner, Eamonn MM Quigley, Lissa Franco, David W Victor III. Autoimmune liver disease and the enteric microbiome. AIMS Microbiology 2018; 4(2): 334 doi: 10.3934/microbiol.2018.2.334
|
92 |
Somaya A. M. Albhaisi, Jasmohan S. Bajaj, Arun J. Sanyal. Role of gut microbiota in liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1): G84 doi: 10.1152/ajpgi.00118.2019
|
93 |
Dongfang Li, Yinhu Li, Wenkui Dai, Huihui Wang, Chuangzhao Qiu, Su Feng, Qian Zhou, Wenjian Wang, Xin Feng, Kaihu Yao, Yanhong Liu, Yonghong Yang, Zhenyu Yang, Ximing Xu, Shuaicheng Li, Jurong Wei, Ke Zhou. Intestinal Bacteroides sp. Imbalance Associated With the Occurrence of Childhood Undernutrition in China. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.02635
|
94 |
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 2023; 13(3): 378 doi: 10.3390/metabo13030378
|
95 |
Qiwei QIAN, Wei HE, Ruqi TANG, Xiong MA. Implications of gut microbiota in autoimmune liver diseases. Minerva Gastroenterology 2023; 69(1) doi: 10.23736/S2724-5985.21.02860-9
|
96 |
Vidushi Aggarwal, Sushant Sunder, Smita Rastogi Verma. Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome. Folia Microbiologica 2022; 67(6): 811 doi: 10.1007/s12223-022-00973-6
|
97 |
Ulrich Wirth, Tianxiao Jiang, Josefine Schardey, Katharina Kratz, Mingming Li, Malte Schirren, Florian Kühn, Alexandr Bazhin, Jens Werner, Markus Guba, Christian Schulz, Joachim Andrassy. The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications. International Journal of Molecular Sciences 2023; 24(5): 4841 doi: 10.3390/ijms24054841
|
98 |
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis. Experimental & Molecular Medicine 2023; 55(7): 1380 doi: 10.1038/s12276-023-01042-9
|
99 |
Yugang Fu, Jiacheng Li, Yingying Zhu, Chong Chen, Jing Liu, Simin Gu, Yiyuan Zheng, Yong Li. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study. BMC Medical Genomics 2023; 16(1) doi: 10.1186/s12920-023-01670-0
|
100 |
Bangzhou Zhang, Luxi Yang, Hanbing Ning, Man Cao, Zhangran Chen, Qiongyun Chen, Guanghui Lian, Hailing Tang, Qizhi Wang, Junping Wang, Zhihui Lin, Jianbo Wen, Yuedong Liu, Ji Xuan, Xuejun Li, Aiqiang Lin, Jianquan He, Lei Zhang, Xiaohua Hou, Qiang Zeng, Chuanxing Xiao, Michael H. Woodworth. A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process. Microbiology Spectrum 2023; 11(1) doi: 10.1128/spectrum.02159-21
|
101 |
Kristopher D. Parker, Shannon E. Albeke, Jason P. Gigley, Allan M. Goldstein, Naomi L. Ward. Microbiome Composition in Both Wild-Type and Disease Model Mice Is Heavily Influenced by Mouse Facility. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.01598
|
102 |
Savini Lanka Britto, Kristi Louise Hoffman, Mary Elizabeth Tessier, Joseph Petrosino, Tamir Miloh, Richard Kellermayer. Microbiome Responses to Vancomycin Treatment in a Child With Primary Sclerosing Cholangitis and Ulcerative Colitis. ACG Case Reports Journal 2021; 8(5): e00577 doi: 10.14309/crj.0000000000000577
|
103 |
Alix Bruneau, Jana Hundertmark, Adrien Guillot, Frank Tacke. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725390
|
104 |
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?. BIOCELL 2021; 45(3): 461 doi: 10.32604/biocell.2021.014332
|
105 |
Andrew M. King, Zhengan Zhang, Emerson Glassey, Piro Siuti, Jon Clardy, Christopher A. Voigt. Systematic mining of the human microbiome identifies antimicrobial peptides with diverse activity spectra. Nature Microbiology 2023; 8(12): 2420 doi: 10.1038/s41564-023-01524-6
|
106 |
Helen Robinson, Helen Barrett, Luisa Gomez-Arango, H. David McIntyre, Leonie Callaway, Marloes Dekker Nitert. Ketonuria Is Associated with Changes to the Abundance of Roseburia in the Gut Microbiota of Overweight and Obese Women at 16 Weeks Gestation: A Cross-Sectional Observational Study. Nutrients 2019; 11(8): 1836 doi: 10.3390/nu11081836
|
107 |
Alzbeta Krausova, Petra Buresova, Lenka Sarnova, Gizem Oyman-Eyrilmez, Jozef Skarda, Pavel Wohl, Lukas Bajer, Eva Sticova, Lenka Bartonova, Jiri Pacha, Gizela Koubkova, Jan Prochazka, Marina Spörrer, Christopher Dürrbeck, Zuzana Stehlikova, Martin Vit, Natalia Ziolkowska, Radislav Sedlacek, Daniel Jirak, Miloslav Kverka, Gerhard Wiche, Ben Fabry, Vladimir Korinek, Martin Gregor. Plectin ensures intestinal epithelial integrity and protects colon against colitis. Mucosal Immunology 2021; 14(3): 691 doi: 10.1038/s41385-021-00380-z
|
108 |
A. Y. Tikunov, V. V. Morozov, A. N. Shvalov, A. V. Bardasheva, E. V. Shrayner, O. A. Maksimova, I. O. Voloshina, V. V. Morozova, V. V. Vlasov, N. V. Tikunova. Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation. Vavilov Journal of Genetics and Breeding 2020; 24(2): 168 doi: 10.18699/VJ20.610
|
109 |
Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBD. Current Gastroenterology Reports 2018; 20(4) doi: 10.1007/s11894-018-0620-2
|
110 |
Lei Zhang, Yong-Na Wu, Tuo Chen, Cheng-Hui Ren, Xun Li, Guang-Xiu Liu. Relationship between intestinal microbial dysbiosis and primary liver cancer. Hepatobiliary & Pancreatic Diseases International 2019; 18(2): 149 doi: 10.1016/j.hbpd.2019.01.002
|
111 |
Shengmin Yan, Xiao-Ming Yin. Gut microbiome in liver pathophysiology and cholestatic liver disease. Liver Research 2021; 5(3): 151 doi: 10.1016/j.livres.2021.08.001
|
112 |
Zhi Feng Dai, Xu Yuan Ma, Rui Yang, Hui Wang, Dan Xu, Jing Yang, Xiao Guo, Shuang Meng, Rui Xu, Yu Li, Yao Xu, Kun Li, Xu Lin. Intestinal flora alterations in patients with ulcerative colitis and their association with inflammation. Experimental and Therapeutic Medicine 2021; 22(5) doi: 10.3892/etm.2021.10757
|
113 |
Atte Sjövall, Velma T.E. Aho, Taneli Hyyrynen, Teemu J. Kinnari, Petri Auvinen, Juha Silvola, Antti Aarnisalo, Anu Laulajainen-Hongisto. Microbiome of the Healthy External Auditory Canal. Otology & Neurotology 2021; 42(5): e609 doi: 10.1097/MAO.0000000000003031
|
114 |
Fatouma Salem, Nadège Kindt, Julian R Marchesi, Patrick Netter, Anthony Lopez, Tunay Kokten, Silvio Danese, Jean-Yves Jouzeau, Laurent Peyrin-Biroulet, David Moulin. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences. United European Gastroenterology Journal 2019; 7(8): 1008 doi: 10.1177/2050640619867555
|
115 |
A Current Understanding of Bile Acids in Chronic Liver Disease. Journal of Clinical and Experimental Hepatology 2022; 12(1): 155 doi: 10.1016/j.jceh.2021.08.017
|
116 |
Beata Kasztelan-Szczerbinska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbinska, Halina Cichoz-Lach. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview. Nutrients 2023; 15(3): 760 doi: 10.3390/nu15030760
|
117 |
Lora J. Kasselman, Nicholas A. Vernice, Joshua DeLeon, Allison B. Reiss. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity. Atherosclerosis 2018; 271: 203 doi: 10.1016/j.atherosclerosis.2018.02.036
|
118 |
Shanshan Guo, Wenye Geng, Shan Chen, Li Wang, Xuli Rong, Shuocun Wang, Tingfang Wang, Liyan Xiong, Jinghua Huang, Xiaobin Pang, Yiming Lu. Ginger Alleviates DSS-Induced Ulcerative Colitis Severity by Improving the Diversity and Function of Gut Microbiota. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.632569
|
119 |
Seyhan Erişir Oygucu, Özlem Bekem. Breastfeeding and Metabolic Programming. 2023; : 83 doi: 10.1007/978-3-031-33278-4_8
|
120 |
Sara Lemoinne, Joao Sabino, Harry Sokol. Gut microbiota in PSC : From association to possible causality. Commentary to “Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis” by Nakamoto et al., Nature Microbiology, January 2019. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): 123 doi: 10.1016/j.clinre.2019.06.005
|
121 |
Jessica R. Allegretti, Zain Kassam, Madeline Carrellas, Benjamin H. Mullish, Julian R. Marchesi, Alexandros Pechlivanis, Mark Smith, Ylaine Gerardin, Sonia Timberlake, Daniel S. Pratt, Joshua R. Korzenik. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial. American Journal of Gastroenterology 2019; 114(7): 1071 doi: 10.14309/ajg.0000000000000115
|
122 |
Yunchang Zhang, Xuemeng Si, Ling Yang, Hui Wang, Ye Sun, Ning Liu. Association between intestinal microbiota and inflammatory bowel disease. Animal Models and Experimental Medicine 2022; 5(4): 311 doi: 10.1002/ame2.12255
|
123 |
Anna M. Hanttu, Satu Pekkala, Reetta Satokari, Anna K. Hartikainen, Perttu Arkkila, Kirsi H. Pietiläinen, Jussi P. Sutinen. Gut microbiota alterations after switching from a protease inhibitor or efavirenz to raltegravir in a randomized, controlled study. AIDS 2023; 37(2): 323 doi: 10.1097/QAD.0000000000003419
|
124 |
Palak J. Trivedi, Gideon M. Hirschfield, David H. Adams, John M. Vierling. Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts. Gastroenterology 2024; 166(6): 995 doi: 10.1053/j.gastro.2024.01.049
|
125 |
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. American Journal of Gastroenterology 2020; 115(6): 814 doi: 10.14309/ajg.0000000000000604
|
126 |
Fangwei Yang, Jinwang Li, Guofang Pang, Fazheng Ren, Bing Fang. Effects of Diethyl Phosphate, a Non-Specific Metabolite of Organophosphorus Pesticides, on Serum Lipid, Hormones, Inflammation, and Gut Microbiota. Molecules 2019; 24(10): 2003 doi: 10.3390/molecules24102003
|
127 |
Nathalie Stummer, René G. Feichtinger, Daniel Weghuber, Barbara Kofler, Anna M. Schneider. Role of Hydrogen Sulfide in Inflammatory Bowel Disease. Antioxidants 2023; 12(8): 1570 doi: 10.3390/antiox12081570
|
128 |
Baorong Jiang, Gehui Yuan, Jialin Wu, Qian Wu, Lei Li, Ping Jiang. Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(3): 166320 doi: 10.1016/j.bbadis.2021.166320
|
129 |
Franco Scaldaferri, Antonio Maria D’Onofrio, Rosaria Calia, Federica Di Vincenzo, Gaspare Filippo Ferrajoli, Valentina Petito, Eleonora Maggio, Pia Clara Pafundi, Daniele Napolitano, Letizia Masi, Elisa Schiavoni, Caterina Fanali, Pierluigi Puca, Laura Turchini, Loris Riccardo Lopetuso, Federica Del Chierico, Lorenza Putignani, Antonio Gasbarrini, and Giovanni Camardese. Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center. Inflammatory Bowel Diseases 2023; 29(11): 1805 doi: 10.1093/ibd/izad091
|
130 |
Agathe Peyrottes, Phillippe Seksik, Joël Doré, Philippe Marteau. Biomarkers in Inflammatory Bowel Diseases. 2019; : 293 doi: 10.1007/978-3-030-11446-6_24
|
131 |
Jennifer T Duong, Christopher E Pope, Hillary S Hayden, Carson Miller, Stephen J Salipante, Steven M Rowe, George M Solomon, David Nichols, Lucas R Hoffman, Michael R Narkewicz, Nicole Green. Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis 2024; 23(3): 490 doi: 10.1016/j.jcf.2024.02.015
|
132 |
Jiali Chen, Yuhang Xiao, Dongmei Li, Shiqing Zhang, Yingzi Wu, Qing Zhang, Weibin Bai. New insights into the mechanisms of high‐fat diet mediated gut microbiota in chronic diseases. iMeta 2023; 2(1) doi: 10.1002/imt2.69
|
133 |
Yizhe Tie, Yongle Huang, Rirong Chen, Li Li, Minhu Chen, Shenghong Zhang. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2265028
|
134 |
J. Maldonado, M. Gil-Campos, J. A. Maldonado-Lobón, M. R. Benavides, K. Flores-Rojas, R. Jaldo, I. Jiménez del Barco, V. Bolívar, A. D. Valero, E. Prados, I. Peñalver, M. Olivares. Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial. BMC Pediatrics 2019; 19(1) doi: 10.1186/s12887-019-1753-7
|
135 |
Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?. Diseases 2019; 7(4): 58 doi: 10.3390/diseases7040058
|
136 |
Tanyaporn Kaenkumchorn, Brooke Musburger, David L. Suskind. Contemporary Dietary Therapies in Inflammatory Bowel Disease. Current Treatment Options in Pediatrics 2021; 7(2): 33 doi: 10.1007/s40746-021-00220-z
|
137 |
Priti Devi, Azka Khan, Partha Chattopadhyay, Aarushi Garg, Rajesh Pandey. Comprehensive Gut Microbiota. 2022; : 400 doi: 10.1016/B978-0-12-819265-8.00080-2
|
138 |
Sara Lemoinne, Astrid Kemgang, Karima Ben Belkacem, Marjolène Straube, Sarah Jegou, Christophe Corpechot, Olivier Chazouillères, Chantal Housset, Harry Sokol. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut 2020; 69(1): 92 doi: 10.1136/gutjnl-2018-317791
|
139 |
Haoan Zhao, Ni Cheng, Wenqi Zhou, Sinan Chen, Qian Wang, Hui Gao, Xiaofeng Xue, Liming Wu, Wei Cao. Honey Polyphenols Ameliorate DSS‐Induced Ulcerative Colitis via Modulating Gut Microbiota in Rats. Molecular Nutrition & Food Research 2019; 63(23) doi: 10.1002/mnfr.201900638
|
140 |
Raffaella Maria Gadaleta, Oihane Garcia-Irigoyen, Marica Cariello, Natasha Scialpi, Claudia Peres, Stefania Vetrano, Gionatha Fiorino, Silvio Danese, Brian Ko, Jian Luo, Emanuele Porru, Aldo Roda, Carlo Sabbà, Antonio Moschetta. Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor. EBioMedicine 2020; 54: 102719 doi: 10.1016/j.ebiom.2020.102719
|
141 |
Tobias J. Weismüller, Taotao Zhou, Sandra Kalthoff, Henrike Lenzen, Michael P. Manns, Christian P. Strassburg, Ana Lleo. Genetic variants of UDP‐glucuronosyltransferase 1A genes are associated with disease presentation and outcome in primary sclerosing cholangitis. Liver International 2020; 40(7): 1645 doi: 10.1111/liv.14487
|
142 |
Wen Zhao, Yijuan Han, Dongyan Shao, Cuicui Han, Yixiao Tian, Qingsheng Huang. Effects of ultra‐strong static magnetic field on the gut microbiota of humans and mice. Bioelectromagnetics 2023; 44(7-8): 211 doi: 10.1002/bem.22482
|
143 |
Malte Rühlemann, Timur Liwinski, Femke‐Anouska Heinsen, Corinna Bang, Roman Zenouzi, Martin Kummen, Louise Thingholm, Marie Tempel, Wolfgang Lieb, Tom Karlsen, Ansgar Lohse, Johannes Hov, Gerald Denk, Frank Lammert, Marcin Krawczyk, Christoph Schramm, Andre Franke. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Alimentary Pharmacology & Therapeutics 2019; 50(5): 580 doi: 10.1111/apt.15375
|
144 |
Levi M. Teigen, Zhuo Geng, Michael J. Sadowsky, Byron P. Vaughn, Matthew J. Hamilton, Alexander Khoruts. Dietary Factors in Sulfur Metabolism and Pathogenesis of Ulcerative Colitis. Nutrients 2019; 11(4): 931 doi: 10.3390/nu11040931
|
145 |
Ayelén D. Rosso, Pablo Aguilera, Sofía Quesada, Florencia Mascardi, Sebastian N. Mascuka, María C. Cimolai, Jimena Cerezo, Renata Spiazzi, Carolina Conlon, Claudia Milano, Gregorio M. Iraola, Alberto Penas-Steinhardt, Fiorella S. Belforte. Comprehensive Phenotyping in Inflammatory Bowel Disease: Search for Biomarker Algorithms in the Transkingdom Interactions Context. Microorganisms 2022; 10(11): 2190 doi: 10.3390/microorganisms10112190
|
146 |
Ruslan A. Mammadov, Jasmijn W. Selten, Henk P. Roest, Cornelia J. Verhoeven, Luca Maroni, Sandra I. Bril, Dagmar Tolenaars, Pravesh S. Gadjradj, Stan F.J. van de Graaf, Ronald P.J. Oude Elferink, Jaap Kwekkeboom, Herold J. Metselaar, Maikel P. Peppelenbosch, Ulrich Beuers, Jan N.M. IJzermans, Luc J.W. van der Laan. Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis. Transplantation 2023; 107(8): 1764 doi: 10.1097/TP.0000000000004563
|
147 |
Jie Xu, Göran Molin, Sanna Davidson, Bodil Roth, Klas Sjöberg, Åsa Håkansson. CRP in Outpatients with Inflammatory Bowel Disease Is Linked to the Blood Microbiota. International Journal of Molecular Sciences 2023; 24(13): 10899 doi: 10.3390/ijms241310899
|
148 |
Rebecca Little, Eytan Wine, Binita M Kamath, Anne M Griffiths, Amanda Ricciuto. Gut microbiome in primary sclerosing cholangitis: A review. World Journal of Gastroenterology 2020; 26(21): 2768-2780 doi: 10.3748/wjg.v26.i21.2768
|
149 |
Phillipp Hartmann. Editorial: The Microbiome in Hepatobiliary and Intestinal Disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.893074
|
150 |
Yu Chengxiao, Wu Dongmei, Zhu Kai, Lijuan Hou, Hang Xiao, Tian Ding, Donghong Liu, Xingqian Ye, Robert J. Linhardt, Shiguo Chen. Challenges of pectic polysaccharides as a prebiotic from the perspective of fermentation characteristics and anti-colitis activity. Carbohydrate Polymers 2021; 270: 118377 doi: 10.1016/j.carbpol.2021.118377
|
151 |
Madeline Alizadeh, Uni Wong, Bernadette C. Siaton, Seema A. Patil, Lauren George, Jean-Pierre Raufman, William H. Scott, Erik C. von Rosenvinge, Jacques Ravel, Raymond K. Cross. Inflammatory Bowel Disease-Associated Arthritis Is Associated with Concomitant Autoimmune and Inflammatory Disorders. Digestive Diseases and Sciences 2024; 69(8): 2961 doi: 10.1007/s10620-024-08478-7
|
152 |
Hirotaka Shimizu, Katsuhiro Arai, Takashi Asahara, Takuya Takahashi, Hirokazu Tsuji, Satoshi Matsumoto, Ichiro Takeuchi, Reiko Kyodo, Yuichiro Yamashiro. Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation. BMC Microbiology 2021; 21(1) doi: 10.1186/s12866-021-02325-9
|
153 |
Shiang Chiet Tan, Chun Wie Chong, Ivan Kok Seng Yap, Kwai Lin Thong, Cindy Shuan Ju Teh. Comparative assessment of faecal microbial composition and metabonome of swine, farmers and human control. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65891-4
|
154 |
Haim Leibovitzh, Shadi Nayeri, Krzysztof Borowski, Cristian Hernandez-Rocha, Sun-Ho Lee, Williams Turpin, Joanne M Stempak, Iqbaljit Sandhu, Raquel Milgrom, Michelle I Smith, Kenneth Croitoru, Gideon M Hirschfield, Aliya Gulamhusein, Mark S Silverberg. Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile. Journal of Crohn's and Colitis 2024; doi: 10.1093/ecco-jcc/jjae096
|
155 |
Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. International Journal of Molecular Sciences 2021; 22(13): 6975 doi: 10.3390/ijms22136975
|
156 |
Kirsten Berding, Sharon M. Donovan. Dietary Patterns Impact Temporal Dynamics of Fecal Microbiota Composition in Children With Autism Spectrum Disorder. Frontiers in Nutrition 2020; 6 doi: 10.3389/fnut.2019.00193
|
157 |
Lingyu Zhu, Yang Song, Huilin Liu, Min Wu, Haizhou Gong, Hainan Lan, Xin Zheng. Gut microbiota regulation and anti‐inflammatory effect of β‐carotene in dextran sulfate sodium‐stimulated ulcerative colitis in rats. Journal of Food Science 2021; 86(5): 2118 doi: 10.1111/1750-3841.15684
|
158 |
Zhao-Hua Shen, Chang-Xin Zhu, Yong-Sheng Quan, Zhen-Yu Yang, Shuai Wu, Wei-Wei Luo, Bei Tan, Xiao-Yan Wang. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World Journal of Gastroenterology 2018; 24(1): 5-14 doi: 10.3748/wjg.v24.i1.5
|
159 |
Xiaoyuan Wei, Kristopher A. Bottoms, Hans H. Stein, Laia Blavi, Casey L. Bradley, Jon Bergstrom, Joshua Knapp, Robert Story, Charles Maxwell, Tsungcheng Tsai, Jiangchao Zhao. Dietary Organic Acids Modulate Gut Microbiota and Improve Growth Performance of Nursery Pigs. Microorganisms 2021; 9(1): 110 doi: 10.3390/microorganisms9010110
|
160 |
Chaoran Zhang, Trana Hussaini, Eric M Yoshida. Review of pharmacotherapeutic treatments for primary sclerosing cholangitis. Canadian Liver Journal 2019; 2(3): 58 doi: 10.3138/canlivj-2018-0016
|
161 |
Stepan Coufal, Natalie Galanova, Lukas Bajer, Zuzana Gajdarova, Dagmar Schierova, Zuzana Jiraskova Zakostelska, Klara Kostovcikova, Zuzana Jackova, Zuzana Stehlikova, Pavel Drastich, Helena Tlaskalova-Hogenova, Miloslav Kverka. Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response. Cells 2019; 8(7): 719 doi: 10.3390/cells8070719
|
162 |
Fan Bu, Yang Ding, Tuo Chen, Qiong Wang, Rong Wang, Jin-yong Zhou, Feng Jiang, Dan Zhang, Minmin Xu, Guoping Shi, Yugen Chen. Total flavone of Abelmoschus Manihot improves colitis by promoting the growth of Akkermansia in mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00070-7
|
163 |
Kentaro Iwasawa, Wataru Suda, Tomoyuki Tsunoda, Manari Oikawa-Kawamoto, Shuichiro Umetsu, Lena Takayasu, Ayano Inui, Tomoo Fujisawa, Hidetoshi Morita, Tsuyoshi Sogo, Masahira Hattori. Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-23870-w
|
164 |
Cynthia L. Hsu, Yi Duan, Derrick E. Fouts, Bernd Schnabl. Intestinal virome and therapeutic potential of bacteriophages in liver disease. Journal of Hepatology 2021; 75(6): 1465 doi: 10.1016/j.jhep.2021.08.003
|
165 |
Mikhail Syromyatnikov, Ekaterina Nesterova, Maria Gladkikh, Yuliya Smirnova, Mariya Gryaznova, Vasily Popov. Characteristics of the Gut Bacterial Composition in People of Different Nationalities and Religions. Microorganisms 2022; 10(9): 1866 doi: 10.3390/microorganisms10091866
|
166 |
Katherine L. Olshan, Ali R. Zomorrodi, Meritxell Pujolassos, Jacopo Troisi, Nayeim Khan, Brian Fanelli, Victoria Kenyon, Alessio Fasano, Maureen M. Leonard. Microbiota and Metabolomic Patterns in the Breast Milk of Subjects with Celiac Disease on a Gluten-Free Diet. Nutrients 2021; 13(7): 2243 doi: 10.3390/nu13072243
|
167 |
Keizo Zeze, Atsushi Hirano, Takehiro Torisu, Motohiro Esaki, Hiroki Shibata, Tomohiko Moriyama, Junji Umeno, Shin Fujioka, Yasuharu Okamoto, Yuta Fuyuno, Yuichi Matsuno, Takanari Kitazono. Mucosal dysbiosis in patients with gastrointestinal follicular lymphoma. Hematological Oncology 2020; 38(2): 181 doi: 10.1002/hon.2717
|
168 |
J. L. Damman, E. A. Rodriguez, A. H. Ali, C. W. Buness, K. L. Cox, E. J. Carey, K. D. Lindor. Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2018; 47(7): 886 doi: 10.1111/apt.14540
|
169 |
Lubomir Skladany, Tomas Koller, Michal Kukla, Katarina Soltys. Predictive, Preventive, and Personalised Medicine: From Bench to Bedside. Advances in Predictive, Preventive and Personalised Medicine 2023; 17: 141 doi: 10.1007/978-3-031-34884-6_9
|
170 |
Lei Wang, Yiwen Wang, Pei Zhang, Chuan Song, Fei Pan, Gang Li, Lihua Peng, Yunsheng Yang, Zhimin Wei, Feng Huang. Gut microbiota changes in patients with spondyloarthritis: A systematic review. Seminars in Arthritis and Rheumatism 2022; 52: 151925 doi: 10.1016/j.semarthrit.2021.11.002
|
171 |
Tingting Duan, Zhiqun Li, Xiaoyong Han, Qichao Hong, Yunan Yang, Jinren Yan, Chengliang Xing. Changes functional prediction of ear canal flora in chronic bacterial otitis externa. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1434754
|
172 |
Johannes R. Hov, Tom H. Karlsen. The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nature Reviews Gastroenterology & Hepatology 2023; 20(3): 135 doi: 10.1038/s41575-022-00690-y
|
173 |
Paige E. Jamieson, Franck Carbonero, Jan F. Stevens. Dietary (poly)phenols mitigate inflammatory bowel disease: Therapeutic targets, mechanisms of action, and clinical observations. Current Research in Food Science 2023; 6: 100521 doi: 10.1016/j.crfs.2023.100521
|
174 |
Zachary White, Ivan Cabrera, Isabel Kapustka, Teruyuki Sano. Microbiota as key factors in inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1155388
|
175 |
Nhan Thi Ho, Fan Li, Shuang Wang, Louise Kuhn. metamicrobiomeR: an R package for analysis of microbiome relative abundance data using zero-inflated beta GAMLSS and meta-analysis across studies using random effects models. BMC Bioinformatics 2019; 20(1) doi: 10.1186/s12859-019-2744-2
|
176 |
Ehud Zigmond, Britta Franziska Zecher, Anna-Lena Bartels, Tomer Ziv-Baran, Thomas Rösch, Guido Schachschal, Ansgar W. Lohse, Hanno Ehlken, Christoph Schramm. Bile Duct Colonization With Enterococcus sp. Associates With Disease Progression in Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 2023; 21(5): 1223 doi: 10.1016/j.cgh.2022.09.006
|
177 |
Zuzana Reiss, Filip Rob, Martin Kolar, Dagmar Schierova, Jakub Kreisinger, Zuzana Jackova, Radka Roubalova, Stepan Coufal, Martin Mihula, Tomas Thon, Lukas Bajer, Michaela Novakova, Martin Vasatko, Klara Kostovcikova, Natalie Galanova, Milan Lukas, Miloslav Kverka, Jana Tresnak Hercogova, Helena Tlaskalova-Hogenova, Zuzana Jiraskova Zakostelska. Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy. Frontiers in Cellular and Infection Microbiology 2023; 12 doi: 10.3389/fcimb.2022.1064537
|
178 |
Ann-Kathrin Lederer, Hannah Rasel, Eva Kohnert, Clemens Kreutz, Roman Huber, Mohamed Tarek Badr, Patricia K. E. Dellweg, Fabian Bartsch, Hauke Lang. Gut Microbiota in Diagnosis, Therapy and Prognosis of Cholangiocarcinoma and Gallbladder Carcinoma—A Scoping Review. Microorganisms 2023; 11(9): 2363 doi: 10.3390/microorganisms11092363
|
179 |
Evaggelia Liaskou, Mohammed Nabil Quraishi, Palak J. Trivedi. Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again. Current Opinion in Gastroenterology 2022; 38(2): 104 doi: 10.1097/MOG.0000000000000809
|
180 |
Angelina Volkova, Kelly V. Ruggles. Predictive Metagenomic Analysis of Autoimmune Disease Identifies Robust Autoimmunity and Disease Specific Microbial Signatures. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.621310
|
181 |
Massimiliano Cadamuro, Mario Strazzabosco. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156: 39 doi: 10.1016/bs.acr.2022.02.001
|
182 |
Shiyu Li, Tianmin Wang, Binning Wu, Wenyi Fu, Baojun Xu, Ramachandra Reddy Pamuru, Mary Kennett, Jairam K.P. Vanamala, Lavanya Reddivari. Anthocyanin-containing purple potatoes ameliorate DSS-induced colitis in mice. The Journal of Nutritional Biochemistry 2021; 93: 108616 doi: 10.1016/j.jnutbio.2021.108616
|
183 |
Nobuhiro Nakamoto, Nobuo Sasaki, Ryo Aoki, Kentaro Miyamoto, Wataru Suda, Toshiaki Teratani, Takahiro Suzuki, Yuzo Koda, Po-Sung Chu, Nobuhito Taniki, Akihiro Yamaguchi, Mitsuhiro Kanamori, Nobuhiko Kamada, Masahira Hattori, Hiroshi Ashida, Michiie Sakamoto, Koji Atarashi, Seiko Narushima, Akihiko Yoshimura, Kenya Honda, Toshiro Sato, Takanori Kanai. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nature Microbiology 2019; 4(3): 492 doi: 10.1038/s41564-018-0333-1
|
184 |
Jinwang Hou, Lina Lian, Lizhi Lu, Tiantian Gu, Tao Zeng, Li Chen, Wenwu Xu, Guoqin Li, Hongzhi Wu, Yong Tian. Effects of Dietary Bacillus coagulans and Tributyrin on Growth Performance, Serum Antioxidants, Intestinal Morphology, and Cecal Microbiota of Growing Yellow-Feathered Broilers. Animals 2023; 13(22): 3534 doi: 10.3390/ani13223534
|
185 |
Miguel Toribio-Mateas, Adri Bester. Precision Medicine for Investigators, Practitioners and Providers. 2020; : 445 doi: 10.1016/B978-0-12-819178-1.00043-5
|
186 |
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entity. Expert Review of Gastroenterology & Hepatology 2022; 16(2): 129 doi: 10.1080/17474124.2022.2031979
|
187 |
Alireza Beheshti Maal, Mohammad Amin Shahrbaf, Bahareh Sadri, Nikoo Hossein-Khannazer, Mohammad Ali Mansournia, Massoud Vosough. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients. Journal of Crohn's and Colitis 2024; 18(3): 360 doi: 10.1093/ecco-jcc/jjad157
|
188 |
Pamela S. Tietz-Bogert, Minsuk Kim, Angela Cheung, James H. Tabibian, Julie K. Heimbach, Charles B. Rosen, Madhumitha Nandakumar, Konstantinos N. Lazaridis, Nicholas F. LaRusso, Jaeyun Sung, Steven P. O’Hara. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis. International Journal of Molecular Sciences 2018; 19(10): 3188 doi: 10.3390/ijms19103188
|
189 |
Katherine JP Schwenger, Nayima Clermont-Dejean, Johane P. Allard. The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Reports 2019; 1(3): 214 doi: 10.1016/j.jhepr.2019.04.004
|
190 |
Daphne M. Rodriguez, Korry J. Hintze, Giovanni Rompato, Arnaud J. Van Wettere, Robert E. Ward, Sumira Phatak, Canyon Neal, Tess Armbrust, Eliza C. Stewart, Aaron J. Thomas, Abby D. Benninghoff. Dietary Supplementation with Black Raspberries Altered the Gut Microbiome Composition in a Mouse Model of Colitis-Associated Colorectal Cancer, although with Differing Effects for a Healthy versus a Western Basal Diet. Nutrients 2022; 14(24): 5270 doi: 10.3390/nu14245270
|
191 |
Rapat Pittayanon, Jennifer T. Lau, Grigorios I. Leontiadis, Frances Tse, Yuhong Yuan, Michael Surette, Paul Moayyedi. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Gastroenterology 2020; 158(4): 930 doi: 10.1053/j.gastro.2019.11.294
|
192 |
Fabine Correia Passos, Marcelo Biondaro Gois, Adenilma Duranes Sousa, Ananda Isis Lima de Marinho, Laura Corvo, Manoel Soto, Manoel Barral-Netto, Aldina Barral, Gyselle Chrystina Baccan. Investigating associations between intestinal alterations and parasite load according to Bifidobacterium spp. and Lactobacillus spp. abundance in the gut microbiota of hamsters infected by Leishmania infantum. Memórias do Instituto Oswaldo Cruz 2020; 115 doi: 10.1590/0074-02760200377
|
193 |
玉杰 李. Relationship between Gut Microbiota and Development and Prognosis of Autoimmune Liver Disease. Advances in Clinical Medicine 2022; 12(11): 10814 doi: 10.12677/ACM.2022.12111557
|
194 |
Harry Sokol, Loic Brot, Carmen Stefanescu, Claire Auzolle, Nicolas Barnich, Anthony Buisson, Mathurin Fumery, Benjamin Pariente, Lionel Le Bourhis, Xavier Treton, Stéphane Nancey, Matthieu Allez, Philippe Seksik. Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn’s disease. Gut 2020; 69(3): 462 doi: 10.1136/gutjnl-2019-318719
|
195 |
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77(2): 659 doi: 10.1002/hep.32771
|
196 |
|
197 |
Asad Ur Rahman, Faisal Inayat, Saeed Ali, Effa Zahid, Roger Charles. The role of oral vancomycin in inducing remission for biologic-experienced ulcerative colitis with concomitant primary sclerosing cholangitis and liver transplantation. Clinical Journal of Gastroenterology 2021; 14(1): 159 doi: 10.1007/s12328-020-01272-8
|
198 |
Ning Wang, Sicong Ma, Lingjie Fu. Gut Microbiota Feature of Senile Osteoporosis by Shallow Shotgun Sequencing Using Aged Rats Model. Genes 2022; 13(4): 619 doi: 10.3390/genes13040619
|
199 |
Ting Long, Zhi-Jun Yu, Jun Wang, Jia Liu, Bing-Shu He. Orally Administered Chitooligosaccharides Modulate Colon Microbiota in Normal and Colitis Mice. International Journal of Pharmacology 2018; 14(2): 291 doi: 10.3923/ijp.2018.291.300
|
200 |
Juri Kazakevych, Jérémy Denizot, Anke Liebert, Mariana Portovedo, Mia Mosavie, Payal Jain, Claudia Stellato, Claire Fraser, Renan Oliveira Corrêa, Marina Célestine, Raphaël Mattiuz, Hanneke Okkenhaug, J. Ross Miller, Marco Aurélio Ramirez Vinolo, Marc Veldhoen, Patrick Varga-Weisz. Smarcad1 mediates microbiota-induced inflammation in mouse and coordinates gene expression in the intestinal epithelium. Genome Biology 2020; 21(1) doi: 10.1186/s13059-020-01976-7
|
201 |
Qiaoyan Liu, Bo Li, Yikang Li, Yiran Wei, Bingyuan Huang, Jubo Liang, Zhengrui You, You Li, Qiwei Qian, Rui Wang, Jun Zhang, Ruiling Chen, Zhuwan Lyu, Yong Chen, Mingxia Shi, Xiao Xiao, Qixia Wang, Qi Miao, Jing-Yuan Fang, Merrill Eric Gershwin, Min Lian, Xiong Ma, Ruqi Tang. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut 2022; 71(5): 899 doi: 10.1136/gutjnl-2020-323565
|
202 |
Laura Manna, Eleonora Rizzi, Eleonora Bafile, Andrea Cappelleri, Massimiliano Ruscica, Chiara Macchi, Michele Podaliri Vulpiani, Romolo Salini, Emanuela Rossi, Concetta Panebianco, Francesco Perri, Valerio Pazienza, Federica Federici. Lentilactobacillus kefiri SGL 13 and Andrographis paniculata alleviate dextran sulfate sodium induced colitis in mice. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1072334
|
203 |
Qiyun Xia, Qiaoyan Liu, Xiong Ma. Intestinal microbiota in biliary diseases. Current Opinion in Gastroenterology 2023; 39(2): 95 doi: 10.1097/MOG.0000000000000910
|
204 |
El Bethel Lalthavel Hmar, Sujata Paul, Nayanmoni Boruah, Priyanka Sarkar, Sudarshana Borah, Hemanta Kumar Sharma. Apprehending Ulcerative Colitis Management With Springing Up Therapeutic Approaches: Can Nanotechnology Play a Nascent Role?. Current Pathobiology Reports 2021; 9(1): 9 doi: 10.1007/s40139-020-00218-6
|
205 |
Masataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, Eyal Weinstock, Iddo Nadav Weiner, Efrat Khabra, Noa Ben-Ishai, Dana Inbar, Noga Kowalsman, Ron Mordoch, Julian Nicenboim, Myriam Golembo, Naomi Zak, Jagoda Jablonska, Hila Sberro-Livnat, Sharon Navok, Nufar Buchshtab, Takahiro Suzuki, Kentaro Miyamoto, Toshiaki Teratani, Sota Fujimori, Yoshimasa Aoto, Mikiko Konda, Naoki Hayashi, Po-Sung Chu, Nobuhito Taniki, Rei Morikawa, Ryosuke Kasuga, Takaya Tabuchi, Shinya Sugimoto, Yohei Mikami, Atsushi Shiota, Merav Bassan, Takanori Kanai. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-39029-9
|
206 |
Cecilia Binda, Giulia Gibiino, Chiara Coluccio, Monica Sbrancia, Elton Dajti, Emanuele Sinagra, Gabriele Capurso, Vittorio Sambri, Alessandro Cucchetti, Giorgio Ercolani, Carlo Fabbri. Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases. Microorganisms 2022; 10(2): 312 doi: 10.3390/microorganisms10020312
|
207 |
Patricia Magadán-Corpas, Álvaro Pérez-Valero, Suhui Ye, Sandra Sordon, Ewa Huszcza, Jarosław Popłoński, Claudio J. Villar, Felipe Lombó. Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol. International Journal of Molecular Sciences 2024; 25(6): 3236 doi: 10.3390/ijms25063236
|
208 |
Arpita Aditya, Catherine Galleher, Yeal Ad, Mitchell Coburn, Aaron Zweig. Gut Microbiome and Its Impact on Health and Diseases. 2020; : 133 doi: 10.1007/978-3-030-47384-6_6
|
209 |
Bahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, Charlotte Ramon, Francisco Damian Bravo, Yannick Franc, Nicolas Fournier, Pierre Michetti, Christoph Mueller, Markus Geuking, Valerie E. H. Pittet, Michel H. Maillard, Gerhard Rogler, Reiner Wiest, Jörg Stelling, Andrew J. Macpherson. Microbial network disturbances in relapsing refractory Crohn’s disease. Nature Medicine 2019; 25(2): 323 doi: 10.1038/s41591-018-0308-z
|
210 |
Sarah Lechner, Matthew Yee, Berkeley N. Limketkai, Edward A. Pham. Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction. Digestive Diseases and Sciences 2020; 65(3): 897 doi: 10.1007/s10620-020-06100-0
|
211 |
Lukáš Bajer, Pavel Wohl, Pavel Drastich. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis. Vnitřní lékařství 2018; 64(6): 659 doi: 10.36290/vnl.2018.090
|
212 |
Mohammed Nabil Quraishi, Walaa A. Shaheen. Editorial: gut microbial profile associated with primary sclerosing cholangitis—what is new and how do we progress from here?. Alimentary Pharmacology & Therapeutics 2019; 50(5): 605 doi: 10.1111/apt.15424
|
213 |
Guillaume C. Onyeaghala, Shweta Sharma, Mosunmoluwa Oyenuga, Christopher M. Staley, Ginger L. Milne, Ryan T. Demmer, Aasma Shaukat, Bharat Thyagarajan, Robert J. Straka, Timothy R. Church, Anna E. Prizment. The Effects of Aspirin Intervention on Inflammation-Associated Lingual Bacteria: A Pilot Study from a Randomized Clinical Trial. Microorganisms 2024; 12(8): 1609 doi: 10.3390/microorganisms12081609
|
214 |
Margarita Aguilera, Yolanda Gálvez-Ontiveros, Ana Rivas. Endobolome, a New Concept for Determining the Influence of Microbiota Disrupting Chemicals (MDC) in Relation to Specific Endocrine Pathogenesis. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.578007
|
215 |
Guillaume Pineton de Chambrun, Maria Nachury, Natalie Funakoshi, Romain Gerard, Michael Bismuth, Jean-Christophe Valats, Fabrizio Panaro, Francis Navarro, Pierre Desreumaux, Benjamin Pariente, Pierre Blanc. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis. European Journal of Gastroenterology & Hepatology 2018; 30(10): 1247 doi: 10.1097/MEG.0000000000001223
|
216 |
Jinbing Bai, Natalie Shen, Yanqun Liu. Associations between the Gut Microbiome and Migraines in Children Aged 7-18 Years: An Analysis of the American Gut Project Cohort. Pain Management Nursing 2023; 24(1): 35 doi: 10.1016/j.pmn.2022.06.002
|
217 |
Dikhnah Al Shehri, Omar I. Saadah, Mahmoud Mosli, Sherif Edris, Marfat Alatawy, Hanan Alatawi, Hadba Al-Amrah, Ibrahim Alatwi, Rashad Al-Hindi, Ahmad Bahieldin. Compositional and functional alteration of gut microbiota profiles in response to anti-TNF-α therapy in inflammatory bowel disease: A Pilot study. Informatics in Medicine Unlocked 2024; 44: 101415 doi: 10.1016/j.imu.2023.101415
|
218 |
Yorick Janssens, Antoon Bronselaer, Evelien Wynendaele, Guy De Tré, Bart De Spiegeleer. Systems Medicine. 2021; : 468 doi: 10.1016/B978-0-12-801238-3.11526-0
|
219 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. HLA, gut microbiome and hepatic autoimmunity. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.980768
|
220 |
Ridda Manzoor, Weshah Ahmed, Nariman Afify, Mashal Memon, Maryam Yasin, Hamda Memon, Mohammad Rustom, Mohannad Al Akeel, Noora Alhajri. Trust Your Gut: The Association of Gut Microbiota and Liver Disease. Microorganisms 2022; 10(5): 1045 doi: 10.3390/microorganisms10051045
|
221 |
Naveen Jeyaraman, Madhan Jeyaraman, Tejaswin Mariappan, Sathish Muthu, Swaminathan Ramasubramanian, Shilpa Sharma, Gabriel Silva Santos, Lucas Furtado da Fonseca, José Fábio Lana. Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentials. World Journal of Gastrointestinal Pharmacology and Therapeutics 2024; 15(6): 98146 doi: 10.4292/wjgpt.v15.i6.98146
|
222 |
Andrew Oliver, Kenza El Alaoui, Carolyn Haunschild, Julio Avelar-Barragan, Laura F. Mendez Luque, Katrine Whiteson, Angela G. Fleischman, Jan Claesen, Yun Du, Abigail Asangba. Fecal Microbial Community Composition in Myeloproliferative Neoplasm Patients Is Associated with an Inflammatory State. Microbiology Spectrum 2022; 10(3) doi: 10.1128/spectrum.00032-22
|
223 |
Zahraa Al Bander, Marloes Dekker Nitert, Aya Mousa, Negar Naderpoor. The Gut Microbiota and Inflammation: An Overview. International Journal of Environmental Research and Public Health 2020; 17(20): 7618 doi: 10.3390/ijerph17207618
|
224 |
Alena Fajstova, Natalie Galanova, Stepan Coufal, Jana Malkova, Martin Kostovcik, Martina Cermakova, Helena Pelantova, Marek Kuzma, Blanka Sediva, Tomas Hudcovic, Tomas Hrncir, Helena Tlaskalova-Hogenova, Miloslav Kverka, Klara Kostovcikova. Diet Rich in Simple Sugars Promotes Pro-Inflammatory Response via Gut Microbiota Alteration and TLR4 Signaling. Cells 2020; 9(12): 2701 doi: 10.3390/cells9122701
|
225 |
Cyriac Abby Philips, Philip Augustine, Nikhil Phadke. Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis – A Single Case Report. Journal of Clinical and Translational Hepatology 2018; 6(xx): 1 doi: 10.14218/JCTH.2018.00033
|
226 |
John P. Haran, Beth A. McCormick. Aging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease. Gastroenterology 2021; 160(2): 507 doi: 10.1053/j.gastro.2020.09.060
|
227 |
Andreas Blesl, Vanessa Stadlbauer. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021; 13(3): 1018 doi: 10.3390/nu13031018
|
228 |
Raed M. Alsulaiman, Abdulaziz A. Al-Quorain, Fahad A. Al-Muhanna, Stanley Piotrowski, Ezzeddin A. Kurdi, Chittibabu Vatte, Ahmed A. Alquorain, Noorah H. Alfaraj, Abdulaziz M. Alrezuk, Fred Robinson, Alexa K. Dowdell, Turki A. Alamri, Lauren Hamilton, Hetal Lad, Hui Gao, Divya Gandla, Brendan J. Keating, Ryan Meng, Brian Piening, Amein K. Al-Ali. Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02904-2
|
229 |
Negin ALMASİ, Arzu KABASAKAL ÇETİN, Zeynep GÖKTAŞ. Anoreksiya Nervosalı Hastalarda İntestinal Mikrobiyotanın Rolü. Psikiyatride Güncel Yaklaşımlar 2022; 14(1): 65 doi: 10.18863/pgy.944592
|
230 |
Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, Piero Portincasa. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. Internal and Emergency Medicine 2023; 18(8): 2181 doi: 10.1007/s11739-023-03343-3
|
231 |
Xiaojie Liu, Mengyu Li, Chen Jian, Xuemei Qin. Characterization of “microbiome-metabolome-immunity” in depressed rats with divergent responses to Paroxetine. Journal of Affective Disorders 2024; 352: 201 doi: 10.1016/j.jad.2024.02.017
|
232 |
Martin Kummen, Johannes R. Hov. The gut microbial influence on cholestatic liver disease. Liver International 2019; 39(7): 1186 doi: 10.1111/liv.14153
|
233 |
Peder Rustøen Braadland, Annika Bergquist, Martin Kummen, Lars Bossen, Lise Katrine Engesæter, Henrik Mikael Reims, Ida Björk, Krzysztof Grzyb, Andreas Abildgaard, Milada Cvancarova Småstuen, Trine Folseraas, Marius Trøseid, Arve Ulvik, Per Magne Ueland, Espen Melum, Pål-Dag Line, Marte Lie Høivik, Henning Grønbæk, Tom Hemming Karlsen, Mette Vesterhus, Johannes Roksund Hov. Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation. Journal of Hepatology 2023; 79(4): 955 doi: 10.1016/j.jhep.2023.05.038
|
234 |
Albane Ruaud, Niklas Pfister, Ruth E. Ley, Nicholas D. Youngblut, Luis Pedro Coelho. Interpreting tree ensemble machine learning models with endoR. PLOS Computational Biology 2022; 18(12): e1010714 doi: 10.1371/journal.pcbi.1010714
|
235 |
Keisaku Sato, Fanyin Meng, Giammarco Fava, Shannon Glaser, Gianfranco Alpini. Functional roles of gut bacteria imbalance in cholangiopathies. Liver Research 2019; 3(1): 40 doi: 10.1016/j.livres.2018.11.001
|
236 |
Angelo Di Giorgio, Diego Vergani, Giorgina Mieli-Vergani. Cutting edge issues in juvenile sclerosing cholangitis. Digestive and Liver Disease 2022; 54(4): 417 doi: 10.1016/j.dld.2021.06.028
|
237 |
Ivana Milosevic, Edda Russo, Ankica Vujovic, Aleksandra Barac, Olja Stevanovic, Stefano Gitto, Amedeo Amedei. Microbiota and viral hepatitis: State of the art of a complex matter. World Journal of Gastroenterology 2021; 27(33): 5488-5501 doi: 10.3748/wjg.v27.i33.5488
|
238 |
Laura Anthamatten, Philipp Rogalla von Bieberstein, Carmen Menzi, Janina N. Zünd, Christophe Lacroix, Tomas de Wouters, Gabriel E. Leventhal. Stratification of human gut microbiomes by succinotype is associated with inflammatory bowel disease status. Microbiome 2024; 12(1) doi: 10.1186/s40168-024-01897-8
|
239 |
Roberto de Paula do Nascimento, Ana Paula da Fonseca Machado, Julio Galvez, Cinthia Baú Betim Cazarin, Mario Roberto Maróstica Junior. Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models. Life Sciences 2020; 258: 118129 doi: 10.1016/j.lfs.2020.118129
|
240 |
Iva Benešová, Ľudmila Křížová, Miloslav Kverka. Microbiota as the unifying factor behind the hallmarks of cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(15): 14429 doi: 10.1007/s00432-023-05244-6
|
241 |
Federica Del Chierico, Sabrina Cardile, Valerio Baldelli, Tommaso Alterio, Sofia Reddel, Matteo Bramuzzo, Daniela Knafelz, Sara Lega, Fiammetta Bracci, Giuliano Torre, Giuseppe Maggiore, Lorenza Putignani. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. Inflammatory Bowel Diseases 2024; 30(4): 529 doi: 10.1093/ibd/izad203
|
242 |
Wen Zeng, Dong He, Yifan Xing, Junyu Liu, Nan Su, Chong Zhang, Yi Wang, Xinhui Xing. Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review. Food Science and Human Wellness 2021; 10(2): 119 doi: 10.1016/j.fshw.2021.02.016
|
243 |
Wan-Ting Cao, Yi-Hong Fan, Bin Lv. Intestinal microbial markers for diagnosis of inflammatory bowel disease. World Chinese Journal of Digestology 2019; 27(3): 190 doi: 10.11569/wcjd.v27.i3.190
|
244 |
Dong Wu, Dan Chen, Wen Shi, Wei Liu, Weixun Zhou, Jiaming Qian, Yu-Chen Fan. Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9936932
|
245 |
Hoang Nam Pham, Linh Pham, Keisaku Sato. Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis. Expert Opinion on Pharmacotherapy 2024; 25(7): 895 doi: 10.1080/14656566.2024.2362263
|
246 |
Gregory Dean, Stephen Hanauer, Josh Levitsky. The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications. Hepatology 2020; 72(3): 1127 doi: 10.1002/hep.31311
|
247 |
Sahil Khanna. Management of Clostridioides difficile infection in patients with inflammatory bowel disease. Intestinal Research 2021; 19(3): 265 doi: 10.5217/ir.2020.00045
|
248 |
Li Gong, Gengsheng Xiao, Liwei Zheng, Xia Yan, Qien Qi, Cui Zhu, Xin Feng, Weilong Huang, Huihua Zhang. Effects of Dietary Tributyrin on Growth Performance, Biochemical Indices, and Intestinal Microbiota of Yellow-Feathered Broilers. Animals 2021; 11(12): 3425 doi: 10.3390/ani11123425
|
249 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation. Gastroenterología y Hepatología (English Edition) 2019; 42(5): 316 doi: 10.1016/j.gastre.2019.02.030
|
250 |
Rui Wang, Ruqi Tang, Bo Li, Xiong Ma, Bernd Schnabl, Herbert Tilg. Gut microbiome, liver immunology, and liver diseases. Cellular & Molecular Immunology 2021; 18(1): 4 doi: 10.1038/s41423-020-00592-6
|
251 |
Radka Roubalová, Petra Procházková, Hana Papežová, Kvido Smitka, Martin Bilej, Helena Tlaskalová-Hogenová. Anorexia nervosa: Gut microbiota-immune-brain interactions. Clinical Nutrition 2020; 39(3): 676 doi: 10.1016/j.clnu.2019.03.023
|
252 |
Martin Kummen, Louise B. Thingholm, Malte C. Rühlemann, Kristian Holm, Simen H. Hansen, Lucas Moitinho-Silva, Timur Liwinski, Roman Zenouzi, Christopher Storm-Larsen, Øyvind Midttun, Adrian McCann, Per M. Ueland, Marte L. Høivik, Mette Vesterhus, Marius Trøseid, Matthias Laudes, Wolfgang Lieb, Tom H. Karlsen, Corinna Bang, Christoph Schramm, Andre Franke, Johannes R. Hov. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis. Gastroenterology 2021; 160(5): 1784 doi: 10.1053/j.gastro.2020.12.058
|
253 |
Pavel Drastich, Lukáš Bajer, Miloslav Kverka. Possibilities of therapeutic manipulation of the gut microbiota. Vnitřní lékařství 2018; 64(6): 665 doi: 10.36290/vnl.2018.091
|
254 |
Frode Norheim, Karthickeyan Chella Krishnan, Thomas Bjellaas, Laurent Vergnes, Calvin Pan, Brian W Parks, Yonghong Meng, Jennifer Lang, James A Ward, Karen Reue, Margarete Mehrabian, Thomas E Gundersen, Miklós Péterfy, Knut T Dalen, Christian A Drevon, Simon T Hui, Aldons J Lusis, Marcus M Seldin. Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis. Molecular Systems Biology 2021; 17(1) doi: 10.15252/msb.20209684
|
255 |
Honghua Zhang, Yuqing Zou, Qingjie Xue, Minhui Li, Huimin Yang, Huijuan Cheng, Yuxin Gu, Chenjia Shen, Qingchang Tian, Shuling Wang. Elemene oral emulsion attenuates colitis in mice by altering gut microbiome and regulating amino acids metabolism. Microbial Pathogenesis 2022; 173: 105821 doi: 10.1016/j.micpath.2022.105821
|
256 |
Haruki Usuda, Takayuki Okamoto, Koichiro Wada. Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier. International Journal of Molecular Sciences 2021; 22(14): 7613 doi: 10.3390/ijms22147613
|
257 |
C. Rodríguez, E. Romero, L. Garrido-Sanchez, G. Alcaín-Martínez, RJ. Andrade, B. Taminiau, G. Daube, E. García-Fuentes. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE. Gut Microbes 2020; 12(1): 1725220 doi: 10.1080/19490976.2020.1725220
|
258 |
Wei-wei Wang, Hong-jie Jia, Hai-jun Zhang, Jing Wang, Hui-yuan Lv, Shu-geng Wu, Guang-hai Qi. Supplemental Plant Extracts From Flos lonicerae in Combination With Baikal skullcap Attenuate Intestinal Disruption and Modulate Gut Microbiota in Laying Hens Challenged by Salmonella pullorum. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01681
|